Spots Global Cancer Trial Database for A Prospective Study on the Treatment of cLM Based on ICG Imaging
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Prospective Study on the Treatment of cLM Based on ICG Imaging
Official Title: A Prospective Randomized Controlled Study on the Treatment of Cystic Lymphatic Malformation Based on Indocyanine Green-fluorescence Imaging
Study ID: NCT06275022
Conditions
Study Description
Brief Summary: The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM. Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation. Researchers will compare difference in curative effect between two groups.
Detailed Description:
Eligibility
Minimum Age: 30 Days
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Children's hospital of Nanjing medical university, Nanjing, Jiangsu, China
Contact Details
Name: Weimin Shen, Dr.
Affiliation: Children's Hospital of Nanjing Medical University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
